Showing results (161-170 of 324) with videos related to
Sort By:
Pageof 33
The British Journal of Cancer. Supplement|June 1, 1978
Clinical studies with misonidazoleC R Wiltshire, P Workman, J V Watson, et al.British Journal of Cancer|October 1, 1990
The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small cell lung cancerJ Hardy, I Smith, G Cherryman, et al.Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I study of oral JM216 given twice dailyP Beale, F Raynaud, J Hanwell, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|June 25, 2004
Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998L Livi, E Andreopoulou, N Shah, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|June 29, 2025
Expanding PARP Inhibitor Use in Prostate Cancer Beyond DNA Repair DefectsA F Palma Dos Reis, L G Faulkner, I W Lai, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumorsR Rampling, G Cruickshank, A D Lewis, et al.Biochemical Pharmacology|September 1, 1990
Doxorubicin-3'-NH-oestrone-17-oxime-ethyl-carbonyl, a doxorubicin-oestrone conjugate that does not redox cycle in rat liver microsomesN G Hartman, L H Patterson, P Workman, et al.Clinical Pharmacology and Therapeutics|January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistanceD Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.Cancer Surveys|January 1, 1993
Pharmacokinetics and early clinical studies of selected new drugsS B Kaye, P Workman, M A Graham, et al.Transfusion Medicine (Oxford, England)|December 20, 2005
Low dose erythropoietin is effective in reducing transfusion requirements following allogeneic HSCTC P Fox, S Pacey, E P Das-Gupta, et al.Pageof 33